The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

NCT06976619 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Type 2 Diabetes

Interventions

DRUG: Liraglutide Pen Injector
OTHER: Saline Injections

Sponsor

Mayo Clinic